Gary L. Rosner

16.6k citations
207 papers · 9.1k indexed · 1 hit paper · h-index 52

Impact in

    • Statistical Methods in Clinical Trials
    • Statistical Methods and Inference
    • Statistical Methods and Bayesian Inference
  • Oncology top 0.5%

Papers in

    • Statistical Methods in Clinical Trials 32
    • Statistical Methods and Bayesian Inference 22
    • Statistical Methods and Inference 20
    • Hematopoietic Stem Cell Transplantation 17
    • Acute Myeloid Leukemia Research 16

Gary L. Rosner

201 papers receiving 8.8k citations

Hit Papers

Phase II Placebo-Controlled Randomized Discontinuation Trial of Sorafenib in Patients With Metastatic Renal Cell Carcinoma 2006 · 794 citations
7942006202620122019250500750

Peers

Gary L. Rosner
Comparison fields: 5 of 178
  • Statistics and Probability 1.3k
  • Oncology 3.0k
  • Hematology 1.1k
  • Cancer Research 1.4k
  • Pulmonary and Respiratory Medicine 1.5k
Replace Nancy L. Geller with:
Nancy L. Geller United States
Stephen L. George United States
Sumithra J. Mandrekar United States
Ram C. Tiwari United States
Boris Freidlin United States
Hajime Uno United States
André Rogatko United States
Richard H. Simon United States
B. Nebiyou Bekele United States
Peter F. Thall United States
Gary L. Rosner relative to Nancy L. Geller United States Nancy L. Geller's profile →
Citations per field
00.5×3.7×
Nancy L. Geller · 1×
Citations per year

Countries citing papers authored by Gary L. Rosner

Since Specialization
Citations

This map shows the geographic impact of Gary L. Rosner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary L. Rosner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary L. Rosner more than expected).

Fields of papers citing papers by Gary L. Rosner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary L. Rosner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary L. Rosner. The network helps show where Gary L. Rosner may publish in the future.

Co-authors

The 25 scholars most cited alongside Gary L. Rosner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary L. Rosner Line = papers co-authored together Gary L. Rosner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202312
2 202175
3 202022
4 201839
5 201861
6 201744
7 201638
8 20152
9 20137
10 20129
11
DPpackage: Bayesian Semi- and Nonparametric Modeling in R
20111
12 2009200
13 200821
14
Phase II Placebo-Controlled Randomized Discontinuation Trial of Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Hit paper breakdown →
2006794
15
A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661.
200239
16 200031
17
Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).
199723
18 199423
19 199225
20 199225

About Gary L. Rosner

Gary L. Rosner is a scholar working on Statistics and Probability, Hematology, Oncology, Cancer Research and Applied Microbiology and Biotechnology, having authored 207 papers that have together received 9.1k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (32 papers), Bayesian Methods and Mixture Models (23 papers), Statistical Methods and Bayesian Inference (22 papers), Statistical Methods and Inference (20 papers), Acute Lymphoblastic Leukemia research (19 papers), Hematopoietic Stem Cell Transplantation (17 papers), Acute Myeloid Leukemia Research (16 papers) and Cancer therapeutics and mechanisms (15 papers). The work is most often cited by research in Statistics and Probability (1.3k citations), Oncology (3.0k citations), Hematology (1.1k citations), Cancer Research (1.4k citations) and Pulmonary and Respiratory Medicine (1.5k citations). Gary L. Rosner has collaborated with scholars based in United States, United Kingdom and Chile. Frequent co-authors include Peter Müller, Mark J. Ratain, Mark W. Dewhirst, Anastasios A. Tsiatis, Walter M. Stadler, Fernando A. Quintana, Maria De Iorio, Donna Hollis, David M. Brizel and Leonard R. Prosnitz. Their work appears in journals such as Journal of Clinical Oncology, Blood, International Journal of Radiation Oncology*Biology*Physics, Biometrics and Biology of Blood and Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026